Back to Search
JULIE BRAHMER, M.D.
M.D.
Medical Oncology Physician
NPI: 1982661989Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
D51770(MD)
Education
OTHER
Class of 1993
Research & Publications (20)
Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.
PMID 17539833·Respirology·2007
6-review
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer.
PMID 19047285·J Clin Oncol·2009
3-trial
Concordance of cancer patients' function, symptoms, and supportive care needs.
PMID 19657724·Qual Life Res·2009
8-other
Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignancies.
PMID 19182243·Oncologist·2009
3-trial
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.
PMID 19224857·J Clin Oncol·2009
3-trial
Phase II trial of gemcitabine/carboplatin followed by paclitaxel in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancer.
PMID 18201795·Lung Cancer·2008
3-trial
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
PMID 18165641·J Clin Oncol·2008
2-rct
Chemotherapy for advanced stage non-small cell lung cancer.
PMID 19038730·Semin Thorac Cardiovasc Surg·2008
6-review
Symptoms, supportive care needs, and function in cancer patients: how are they related?
PMID 18493865·Qual Life Res·2008
8-other
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.
PMID 18379785·Cancer Chemother Pharmacol·2008
3-trial
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
PMID 18309947·J Clin Oncol·2008
4-observational
Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.
PMID 18235126·J Clin Oncol·2008
3-trial
Asking the right questions: investigating needs assessments and health-related quality-of-life questionnaires for use in oncology clinical practice.
PMID 17318591·Support Care Cancer·2007
8-other
"Who should receive epidermal growth factor receptor inhibitors for non-small cell lung cancer and when?".
PMID 17634830·Curr Treat Options Oncol·2007
6-review
Targeting the epidermal growth factor receptor in non-small-cell lung cancer: who, which, when, and how?
PMID 17588349·Curr Oncol Rep·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 N WOLFE ST
BALTIMORE, MD 21287 - Phone
- (410) 955-8964
Quick Facts
- NPI
- 1982661989
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile